CLINICAL STUDY
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect
A report from the NHLBI-sponsored WISE study
Marian B. Olson, MSa,
Sheryl F. Kelsey, PhDa,
Vera Bittner, MD, FACCb,
Steven E. Reis, MD, FACCc,
Nathaniel Reichek, MD, FACCd,
Eileen M. Handberg, PhDe,
C. Noel Bairey Merz, MD, FACCf for the Womens Ischemia Syndrome Evaluation (WISE) Study Group
a Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
b the Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
c the Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
d the Division of Cardiology, Allegheny General Hospital, MCP-Hahnemann School of Medicine, Pittsburgh, Pennsylvania, USA
e the University of Florida, Division of Cardiovascular Medicine, Gainesville, Florida, USA
f the Division of Cardiology, Department of Medicine, Cedars-Sinai Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
Manuscript received December 3, 1999;
revised manuscript received April 13, 2000,
accepted June 16, 2000.
Reprint requests and correspondence: Marian B. Olson, c/o WISE Coordinating Center, University of Pittsburgh, 127 Parran Hall, Graduate School of Public Health, 130 DeSoto Street, Pittsburgh, Pennsylvania 15261 olson{at}edc.gsph.pitt.edu
OBJECTIVES
We undertook an analysis of weight cycling, coronary risk factors and angiographic coronary artery disease (CAD) in women.
BACKGROUND
The effect of weight cycling on cardiovascular mortality and morbidity is controversial, and the impact of weight cycling on cardiovascular risk factors is unclear.
METHODS
This is a cross-sectional population study of 485 women with coronary risk factors undergoing coronary angiography for evaluation of suspected myocardial ischemia enrolled in the Womens Ischemia Syndrome Evaluation (WISE). Reported lifetime weight cyclingdefined as voluntary weight loss of at least 10 lbs at least 3 timescoronary risk factors including core laboratory determined blood lipoproteins and CAD, as determined by a core angiographic laboratory, are the main outcome measures.
RESULTS
Overall, 27% of women reported weight cycling19% cycled 10 to 19 lbs, 6% cycled 20 to 49 lbs, and 2% cycled 50+ lbs. Reported weight cycling was associated with 7% lower high-density lipoprotein cholesterol (HDL-C) levels in women (p = 0.01). The HDL-C effect was directly related to the amount of weight cycled with women who lost 50 lbs/cycle having HDL-C levels 27% lower than noncyclers (p = 0.0025). This finding was independent of other HDL-C modulators, including estrogen status, physical activity level, alcohol intake, body mass index, diabetes, beta-blocker use, cigarette smoking and race. Weight cycling was not associated with an increased prevalence of CAD in this population.
CONCLUSIONS
Weight cycling is associated with lower HDL-C in women of a magnitude that is known to be associated with an increased risk of cardiac events as demonstrated in prior clinical trials.
|
Abbreviations and Acronyms
| | BMI | = body mass index | | CAD | = coronary artery disease | | HDL-C | = high-density lipoprotein cholesterol | | HRT | = hormone replacement therapy | | NHLBI | = National Heart, Lung and Blood Institute | | PEPI-Q | = Postmenopausal Estrogen/Progesterone Intervention Activity Questionnaire | | TC | = total plasma cholesterol | | WISE | = Womens Ischemia Syndrome Evaluation |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Sogaard, H. E. Meyer, S. Tonstad, L. L. Haheim, and I. Holme
Weight Cycling and Risk of Forearm Fractures: A 28-Year Follow-up of Men in the Oslo Study
Am. J. Epidemiol.,
April 15, 2008;
167(8):
1005 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Christen, Z. Efstathiadou, E. Laspa, D. G. Johnston, and I. F. Godsland
Rate of Change and Instability in Body Mass Index, Insulin Resistance, and Lipid Metabolism as Predictors of Atherosclerotic Vascular Disease
J. Clin. Endocrinol. Metab.,
October 1, 2007;
92(10):
3780 - 3787.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Wilson and D. D. McAlpine
The Effectiveness of Screening for Obesity in Primary Care: Weighing the Evidence
Med Care Res Rev,
October 1, 2006;
63(5):
570 - 598.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Wessel, C. B. Arant, M. B. Olson, B. D. Johnson, S. E. Reis, B. L. Sharaf, L. J. Shaw, E. Handberg, G. Sopko, S. F. Kelsey, et al.
Relationship of Physical Fitness vs Body Mass Index With Coronary Artery Disease and Cardiovascular Events in Women
JAMA,
September 8, 2004;
292(10):
1179 - 1187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. McTigue, R. Harris, B. Hemphill, L. Lux, S. Sutton, A. J. Bunton, and K. N. Lohr
Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med,
December 2, 2003;
139(11):
933 - 949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stangl, G. Baumann, and K. Stangl
Coronary atherogenic risk factors in women
Eur. Heart J.,
November 2, 2002;
23(22):
1738 - 1752.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Weight Cycling Associated with Lower HDL Levels in Women
Journal Watch Women's Health,
December 4, 2000;
2000(1204):
12 - 12.
[Full Text]
|
 |
|

|
 |

|
 |
 
Weight Cycling Associated with Lower HDL Levels in Women
Journal Watch (General),
November 17, 2000;
2000(1117):
3 - 3.
[Full Text]
|
 |
|
|